Anupam Rasayan India Ltd., a custom synthesis manufacturer of speciality chemicals, has announced the signing of a definitive agreement to acquire a 100% equity stake in Jayhawk Fine Chemicals Corporation, a U.S.-based speciality chemical company and part of CABB Group, for a purchase consideration of $150 million.
The purchase consideration accounts for payment against the equity value of Jayhawk and existing loans payable to the exiting shareholders.
Considering $16 million of cash and cash-like items for Jayhawk as ofJune 25, the purchase consideration translates to an enterprise value of $134 million.
Jayhawker clocked revenues and adjusted EBITDA of $78 million and $15 million respectively in CY24.
The acquisition will be financed through a mix of internal accruals, debt and quasi equity from a leading global investment management firm.
Anand Desai, Managing Director, Anupam Rasayan India Ltd., said, “This acquisition is a transformative step in Anupam’s global journey. Jayhawk brings to us a legacy of innovation, deep customer relationships, and a strong technology platform in high-value chemistries. Together, we will leverage our complementary strengths to accelerate growth, enhance our global presence, and deliver greater value to customers across key sectors such as aviation, semiconductors and electronics.”
“The addition of Jayhawk’s U.S. operations significantly strengthens our global footprint and positions us closer to strategic customers in developed markets,” he added.
Tobias Schalow, CEO, CABB Group, said, “This transaction marks a strategic step for our company, and we have made this decision with the utmost confidence and trust in the new owner. We have developed a scalable growth platform in Pharma and Life Science specialities, which we will further develop and expand, and shift away from industrial applications, electronics and semiconductors with this transaction.”
Published – December 10, 2025 04:20 am IST
